학술논문
238 A randomized, double-blind placebo-controlled study of NV1FGF gene therapy in critical limb ischemia patients (TAMARIS Study): Rationale, design and baseline patient characteristics
Document Type
Abstract
Author
Source
In Archives of Cardiovascular Diseases Supplements 2011 3(1):77-78
Subject
Language
ISSN
1878-6480